Company

Hengrui Pharmaceuticals Appoints Dr. Jiang Ningjun as Deputy General Manager and CSO

CompanyDrug

Junshi Biosciences’ CGRP Monoclonal Antibody JS010 Accepted for NMPA Review

CompanyDrug

BeiGene’s Tislelizumab Receives NMPA Review for First-Line HCC Indication

CompanyDeals

Immunohead Biotech Raises RMB 200 Million in Series A+ Financing Round

CompanyDeals

Biocytogen and Hansoh Enter Antibody Collaboration and Licensing Agreement

CompanyDrug

CStone Pharmaceuticals Achieves Primary Endpoint in GEMSTONE-304 Study for Sugemalimab

CompanyDrug

3D Medicines Gains FDA Approval for Phase II Study of Envafolimab in dMMR Tumors

CompanyDrug

Changzhou Qianhong Completes Phase I Study of QHRD107 for Acute Myeloid Leukemia

CompanyDrug

Guangdong Zhongsheng Completes Enrollment for RAY1216 Phase III Study in COVID-19

DrugPolicy / Regulatory

CDE Releases 65th Batch of Chemical Generic Reference Preparations

CompanyDrug

Viking Therapeutics Sues Ascletis Pharma Over Alleged Trade Secret Theft

CompanyDeals

Shuwen Biotech Partners with Nottingham University Hospitals for MammaTyper